
WILMINGTON – AstraZeneca has named Rick R. Suarez Senior Vice President, US President and Head of the US BioPharmaceuticals Business Unit after 26 years with the company.
Suarez will lead the execution of the $50 billion US research, development and manufacturing investment, including construction of a $4.5 billion manufacturing facility in Virginia, AstraZeneca’s largest single…
…
Continue reading this article at;
https://delawarebusinesstimes.com/news-briefs/astrazeneca-names-rick-suarez-us-president/
delawarebusinesstimes.com
Feed Name : Delaware Business Times
News Briefs,AstraZeneca
hashtags : #AstraZeneca #names #Rick #Suarez #President
